SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-050292
Filing Date
2023-10-30
Accepted
2023-10-30 17:17:21
Documents
24
Period of Report
2023-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20009756x10_8k.htm   iXBRL 8-K 116995
2 EXHIBIT 3.1 ny20009756x10_ex3-1.htm EX-3.1 15558
3 EXHIBIT 3.2 ny20009756x10_ex3-2.htm EX-3.2 31636
4 EXHIBIT 3.3 ny20009756x10_ex3-3.htm EX-3.3 202122
5 EXHIBIT 4.1 ny20009756x10_ex4-1.htm EX-4.1 112188
6 EXHIBIT 10.1 ny20009756x10_ex10-1.htm EX-10.1 214934
7 EXHIBIT 10.2 ny20009756x10_ex10-2.htm EX-10.2 201055
8 EXHIBIT 10.3 ny20009756x10_ex10-3.htm EX-10.3 74805
9 EXHIBIT 10.4 ny20009756x10_ex10-4.htm EX-10.4 113477
10 EXHIBIT 10.5 ny20009756x10_ex10-5.htm EX-10.5 105827
11 EXHIBIT 14.1 ny20009756x10_ex14-1.htm EX-14.1 89573
12 EXHIBIT 99.1 ny20009756x10_ex99-1.htm EX-99.1 9742
16 image0.jpg GRAPHIC 631
  Complete submission text file 0001140361-23-050292.txt   1698308

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA cbio-20231027.xsd EX-101.SCH 3907
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20231027_lab.xml EX-101.LAB 23291
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20231027_pre.xml EX-101.PRE 16580
18 EXTRACTED XBRL INSTANCE DOCUMENT ny20009756x10_8k_htm.xml XML 4366
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130 650-266-8674
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 231361476
SIC: 2834 Pharmaceutical Preparations